Results 151 to 160 of about 39,459 (267)

Biomarker‐directed aptamer panels for diagnosis and differentiation of neuroendocrine tumors

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract Neuroendocrine tumors (NETs) are rare tumors that may arise in the small intestine (siNET) or pancreas (pNET). The tumors have heterogeneous clinical characteristics, and diagnosis may be challenging. Current non‐invasive biomarkers perform suboptimally, and novel biomarkers are highly needed.
Mikkel Breinholt Kjær   +8 more
wiley   +1 more source

Significance of plasma chromogranin A determination in neuroendocrine tumour (NET) diagnosis

open access: yesFolia Histochemica et Cytobiologica, 2010
The secretory nature of NETs implies the determination of the CgA concentration as a standard marker. The concentrationof CgA in plasma correlates with the degree of histopathological differentiation, tumor stage, and is an essentialprerequisite for ...
H. Donica   +4 more
doaj  

Proteomic insights into the invasiveness and tumor progression of non‐functioning pituitary adenomas: A scoping review

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract Nonfunctioning pituitary adenomas (NFPAs) are common intracranial tumors that, despite being histologically benign, can exhibit invasive growth, as well as postoperative tumor progression. Surgical resection is the primary treatment of choice; however, residual tumor tissue is frequently observed, with between 30% and 50% of these cases ...
Thomas Skoglund   +5 more
wiley   +1 more source

Blue‐Gray Papules on the Chest and Face

open access: yes
JEADV Clinical Practice, Volume 5, Issue 1, Page 326-329, March 2026.
Sanjana Likki   +5 more
wiley   +1 more source

Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 11-20, March 2026.
ABSTRACT Canine phaeochromocytomas (PCCs) are neuroendocrine tumours with malignant potential. Metastatic disease remains the sole definitive evidence of malignancy. Histopathological criteria to predict long‐term survival have not been established in dogs.
Marit F. van den Berg   +6 more
wiley   +1 more source

Markers for neural and endocrine cells [PDF]

open access: yes, 1991
Gratzl, Manfred   +2 more
core   +1 more source

Gastric Neuroendocrine Tumor: A Report of a Rare Case. [PDF]

open access: yesCureus
Mduma E   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy